금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Here’s the real signal to watch for the Fed’s next move
Investors should focus not on the rate itself, but on where financial conditions are...
President Donald Trump Just Proclaimed, "Tariffs Don't Cause Inflation, They Cause Wealth," but Data From Federal Reserve Economists Show Otherwise
Statistically speaking, tariffs have been bad news for Wall Street and consumers....
This Stock Market Metric Warns History May Be Repeating Itself. Here's How the Smartest Investors Are Preparing.
A bear market could be on the way, but the right strategy can protect your portfolio....
3 Reasons to Avoid SOLV and 1 Stock to Buy Instead
Solventum’s 22% return over the past six months has outpaced the S&P 500 by 10.4%, and its stock price has climbed to $89.05 per share. This was partly due to its solid quarterly results, and the run- ...
Stock Market Today: Dow Waffles As Warsh Speech Wraps; Microsoft Breaks Out, Amazon Jumps (Live Coverage)
The Dow Jones Industrial Average waffled early Friday after Federal Reserve Chair Kevin Warsh wrapped up his speech at the Fed's annual symposium in Jackson Hole, Wyo. Meanwhile, Rubrik, Marvell Techn ...
3 Big Reasons to Love Eli Lilly (LLY)
Eli Lilly trades at $1,175 per share and has stayed right on track with the overall market, gaining 15.4% over the last six months. At the same time, the S&P 500 has returned 11.6%.
Albany (AIN): Buy, Sell, or Hold Post Q2 Earnings?
Albany currently trades at $59.13 per share and has shown little upside over the past six months, posting a small loss of 0.8%. The stock also fell short of the S&P 500’s 11.6% gain during that period ...
Assessing Mercado Libre’s (MELI) Strategic Reinvestment: A Path to Growth
Hayden Capital, an investment management firm, released its second-quarter 2026 investment letter. The letter can be downloaded here. In the second quarter, the portfolio gained 6.9%, compared to the ...
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals?
VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.
Barclays Gains 34.2% in a Year: Is There Further Upside Potential?
Barclays has gained 34.2% over the past year as core growth and stronger earnings support momentum, while elevated costs and regulatory demands pose risks.
Wendy’s Climbs 4%, McDonald’s Ticks Up: Is Short Interest Setting Up a Squeeze in the Burger Trade?
Wendy's short interest has climbed to one of its highest readings on record, and a sudden 4% snapback after a brutal single-session collapse is raising an uncomfortable question for anyone still holdi ...
Silgan (SLGN) Up 1.9% Since Last Earnings Report: Can It Continue?
Silgan (SLGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Starbucks (SBUX) Up 1.3% Since Last Earnings Report?
Starbucks (SBUX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Is Sonos (SONO) Up 4.6% Since Last Earnings Report?
Sonos (SONO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
SoFi Technologies (SOFI) Up 16.5% Since Last Earnings Report: Can It Continue?
SoFi Technologies (SOFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.